
25/07/2025
🧬 Inflammation Aging: What Gets Measured, Gets Managed
As we continue shaping the future of performance and regenerative medicine, chronic inflammation is proving to be one of the most consistent and predictive markers of biological aging.
According to Singh Newman (2011), long-term population studies show that elevated levels of inflammatory markers like IL-6, CRP, and TNF-α are strongly associated with:
Sarcopenia physical frailty
Cognitive decline
Cardiovascular disease
Poor recovery functional limitations
Increased all-cause mortality
In short: inflammation isn’t just a response—it’s a driver of aging.
⚠️ The problem? These markers are rarely tested in routine health checks.
They fluctuate, they’re complex to interpret, and they don’t fit the reductive model of “you’re fine until you’re sick.” But the science is clear:
Even low-grade, subclinical inflammation (what many call “inflammaging”) accelerates physiological breakdown years before diagnosis.
💡 This is why new diagnostic strategies must move beyond basic panels.
We need systems that quantify and track inflammatory load, redox balance, and autonomic regulation—not just look for disease, but anticipate dysfunction.
And we need therapeutic frameworks that don’t just suppress inflammation, but rebalance the systems that regulate it.
What we’re building is rooted in this science. A new level of care—precise, proactive, and personal.
Inflammaging